BioCardia (BCDA) Capital Expenditures Growth (1y) (2018 - 2025)
Powered by 
Analysis
BioCardia (BCDA) Capital Expenditures Growth (1y) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 87.24% |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | -27.07% |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn | 18.48% |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.40 Bn | 251.87 Mn | -98.25% |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | -78.75% |
| 10 | BioCardia | 13.18 Mn | 9.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 500.00% |
| Jun 30, 2025 | -66.67% |
| Jun 30, 2024 | 50.00% |
| Jun 30, 2023 | -92.00% |
| Mar 31, 2023 | -65.52% |
| Dec 31, 2022 | -95.12% |
| Sep 30, 2022 | -30.00% |
| Jun 30, 2022 | -10.71% |
| Mar 31, 2022 | 7.41% |
| Sep 30, 2021 | -13.04% |
| Jun 30, 2021 | 600.00% |
| Mar 31, 2021 | 440.00% |
| Sep 30, 2020 | 15.00% |
| Jun 30, 2020 | -94.20% |
| Mar 31, 2020 | -90.91% |
| Dec 31, 2019 | -86.67% |
| Sep 30, 2019 | 300.00% |
| Jun 30, 2019 | 68.29% |
| Mar 31, 2019 | 1,000.00% |
| Dec 31, 2018 | -48.28% |